drugset / Trial / NCT01076699
A Four Arm Study to Evaluate the Safety and Efficacy of 3 Different Doses of RVX-100 Versus Placebo in Subjects With Irritable Bowel Syndrome Accompanied by Diarrhea (IBS-D)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if RVX-100 is safe and effective in treating acute abdominal pain in patients with irritable bowel syndrome accompanied by diarrhea.
Timeline
- Start
- 2010-03
- Primary completion
- 2010-12
- Completion
- 2011-03
Outcome
Outcome not reported
Stopped (Enrollment): “recruiting/enrolling participants has halted prematurely but potentially will resume Oct”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | RVX-100 | Unknown | 0.075 mg | — |
| Comparator | RVX-100 | Unknown | 0.125 mg | — |
| Comparator | RVX-100 | Unknown | 0.25 mg | — |